Supurva Healthcare Group Announces Substantial Upgrade to Acquisition LOI with Telemend Medical Supurva Expects Major Breakout

Supurva Healthcare Group Announces Substantial Upgrade to Acquisition LOI with Telemend Medical
 

Supurva Expects Major Breakout Year in 2015; Upwards of $2 Million in Revenues Expected Over The Next Twelve Months

Covington, LA -- July 16, 2015 -- InvestorsHub NewsWire -- Supurva Healthcare Group, Inc. (Formerly known as Lighthouse Petroleum, Inc.) (Supurva or the Company) (OTC Markets: SPRV), is pleased to announce today that the Company has upgraded the letter of intent (LOI) to acquire Telemend Medical (Telemend) announced on July 8, 2015 to now include existing clinical engineering contracts with various government entities nationwide. Under these additional contracts, the Company will be initiating a hybrid of clinical engineering and IT services alongside the Companys mobile healthcare services providing for a best-in-class telemedicine delivery system. These contracts are expected to add in excess of $400,000 in revenues over the next twelve months to the total acquisition package. This is in addition to the other contracts under the LOI to provide services to 35 dental facilities in the Greater Houston area that are expected to generate more than $1.6 million in revenues for the Company over the next twelve months.

Current CEO of Telemend, Sheneka Rains, has agreed to remain as CEO of Telemend after its acquisition and will also serve as COO of Supurva. After completion of the transaction, she will be well positioned for further expansion of the Company, bringing with her many years of experience managing clinical engineering contracts and having established operational excellence amongst a variety of healthcare business models. In her tenure as CEO of Telemend, Ms. Rains has doubled total customer accounts and tripled revenue.

Gerard Danos, CEO of Supurva stated, Clinical engineering will provide a steady revenue stream that will allow us to far exceed our projected targets for 2015. This level of revenues will enable the Company to quickly reach its goal to achieve fully reporting status as soon as possible. I am also thrilled that Ms. Rains will join our organization to ensure a smooth transition of existing customers as well as establish operational systems that will facilitate additional future acquisitions.

About Supurva Healthcare Group, Inc.

Supurva Healthcare Group, Inc., a Delaware Corporation, is a healthcare holdings company based in Covington, LA. Supurva, through its wholly own subsidiary On Site Solutions, LLC, provides on-site healthcare for acute, subacute, and nursing facility residents / patients; specializing in dentistry, podiatry, optometry, and wound care. On Site Solutions, LLC currently has arrangements with 14 long term care facilities in Texas in its growing portfolio totaling roughly 1200 beds.

Forward Looking Statement

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements describe future expectations, plans, results, or strategies and are generally preceded by words such as may, future, plan or planned, will or should, expected, anticipates, draft, eventually or projected. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks. Supurva Healthcare Group, Inc. is a healthcare holdings company. At the time of this release Supurva Healthcare Group, Inc. lacks the financial capabilities to meet its financial obligations and its management expects to dilute the companys shares to raise the necessary operating capital. Based upon industry standards Supurva would be considered highly speculative and lacks any competitive advantage over its competition. Additional risks you should consider are that this list is limited and additional risk not mentioned may apply: failure to meet Supurvas financial and contractual obligations, Supurvas managerial errors made based upon the Companys limited experience and knowledge of the industry, acts of God and regulatory risk. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements.

Contact

Gerard Danos, Chairman
Supurva Healthcare Group, Inc.
[e-mail]

1-985-237-3701